Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-10-14

FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (AiPing Pharmaceutical, Inc.)

View source ↗

Summary

FDA approved AiPing Pharmaceutical's supplemental application for losartan potassium.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Losartan Potassium (Losartan potassium)

Snippet

SUPPL AP for LOSARTAN POTASSIUM (LOSARTAN POTASSIUM)